Mangalam Drugs & Organics P/B Ratio
Mangalam Drugs & Organics (MANGALAM) P/B ratio is 0.4 (Low), book value per share ₹64.38 vs Healthcare average P/B of -0.93 — Very Low - Significant discount to book value, potential distress or value opportunity. For live price, earnings yield and the full fundamental profile, see MANGALAM stock price BSE.
Current Valuation Metrics
Book Value Breakdown (2026)
Valuation Signal
Sector Context
MANGALAM P/B Ratio — Valuation Insights & Book Value Analysis
Mangalam Drugs & Organics price-to-book ratio interpretation, valuation status and historical context — current P/B 0.4 (Low). Compare with MANGALAM stock valuation models to assess whether the stock is under or overvalued.
- Stock appears undervalued with PB of 0.4, trading below book value
- Trading below book value - potential value opportunity or financial distress signal
- Current PB is 43.1% below historical average
- Trading at premium to sector average PB of -0.93
Mangalam Drugs & Organics P/B Ratio Historical Trend
MANGALAM annual price-to-book ratio — 3 years, book value per share and year-end price. P/B below 1.0 indicates the stock trades below net asset value. View MANGALAM 52-week high low for the annual high/low range and current price position.
MANGALAM Historical P/B Ratio — Book Value Per Share & Year-End Price
Mangalam Drugs & Organics annual P/B ratio, book value per share (₹), year-end price and total equity in ₹ Crores.
| Year | P/B Ratio | Book Value/Share (₹) | Year-end Price (₹) | Total Equity (₹ Cr) | Valuation |
|---|---|---|---|---|---|
| 2026 | 0.45 | ₹64.38 | ₹29.27 | ₹103 | Low |
| 2025 | 0.3 | ₹93.12 | ₹27.51 | ₹149 | Low |
| 2024 | 1.36 | ₹85.0 | ₹115.48 | ₹136 | Moderate |
MANGALAM vs Healthcare Peers — P/B Ratio Comparison
Mangalam Drugs & Organics P/B 0.4 vs Healthcare average -0.93, median 0.61 — range -31.21–1.04.
| Company | Symbol | P/B Ratio | Market Cap (₹ Cr) | Valuation |
|---|---|---|---|---|
| Rekvina Laboratories | VINRKLB | -31.21 | ₹25 | Low |
| Sun Pharma Advanced Rese… | SPARC | -16.05 | ₹5,310 | Low |
| Span Divergent | SDL | -6.32 | ₹19 | Low |
| Oxygenta Pharmaceutical | OXYGENTAPH | -5.54 | ₹203 | Low |
| Satiate Agri | SATAGRI | -3.39 | ₹8 | Low |
| Adline Chem Lab | ADLINE | -3.03 | ₹5 | Low |
| Bharat Immunologicals | BIBCL | -2.31 | ₹75 | Low |
| Parmax Pharma | PARMAX | -2.16 | ₹12 | Low |
| Krebs Biochemicals & Ind… | KREBSBIO | -0.76 | ₹121 | Low |
| Cresanto Global | CRESANTO | -0.7 | ₹2 | Low |